[Immunotropic activity of adapiprazine]

Area of Science:

• Immunology
• Pharmacology
• Drug Discovery

Background:

• Aethaperazine and metherazine are known compounds.
• Structural modification of drug molecules can alter their biological activity.
• The role of adamantyl radicals in immunomodulation is not well-established.

Purpose of the Study:

• To investigate the immunotropic activity of adapiprazine, a novel adamantyl-substituted derivative of aethaperazine/metherazine.
• To evaluate the immunodepressive effects of adapiprazine on primary and secondary immune responses.
• To assess the efficacy of adapiprazine in preventing allograft rejection.

Main Methods:

• Immunization of mice with sheep erythrocytes to assess primary and secondary immune responses.
• Administration of adapiprazine, aethaperazine, and metherazine at varying dosages before immunization.
• Evaluation of skin allotransplant rejection in mice.
• In vitro assessment of adapiprazine's effect on leukocyte migration and rosette formation.

Main Results:

• Adapiprazine exhibited a singular immunotropic activity, exerting an immunodepressive action on both primary and secondary immune responses in mice.
• The immunodepressive effect of adapiprazine was optimal at low dosages administered prior to immunization.
• Adapiprazine successfully arrested the rejection of skin allografts in mice.
• In vitro tests showed no significant effect of adapiprazine on spontaneous leukocyte migration or immune rosette formation at concentrations of 10(-5) mol and below.

Conclusions:

• The introduction of an adamantyl radical into the molecular structure of aethaperazine/metherazine confers significant immunodepressive properties, as exemplified by adapiprazine.
• Adapiprazine is a potent immunomodulator capable of suppressing adaptive immunity and prolonging allograft survival.
• Further research into adapiprazine's mechanism of action and therapeutic potential is warranted.